The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients
William G. Dunn(Wellcome/MRC Cambridge Stem Cell Institute), George S. Vassiliou(Wellcome/MRC Cambridge Stem Cell Institute), Paul Costeas(Deakin University), Jiangxiang Chi, Margarete A. Fabre(University of Cambridge), Muxin Gu(Wellcome/MRC Cambridge Stem Cell Institute), Laura Koumas, Jonathan Cooper(Wellcome Sanger Institute), Katerina Nicolaou, Josep Nomdedéu(Centre de Recherche Jean Pierre Aubert)
Cited by 1
Related Papers
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
|Cell Reports|2016|834
Mitochondrial defect in Huntington's disease caudate nucleus
|Annals of Neurology|1996|738
Molecular and functional characterization of the Salmonella invasion gene invA: homology of InvA to members of a new protein family
|Journal of Bacteriology|1992|586
Clonal dynamics of haematopoiesis across the human lifespan
|Nature|2022|505